InvestorsHub Logo
Followers 0
Posts 8
Boards Moderated 0
Alias Born 11/07/2017

Re: None

Thursday, 01/25/2018 10:56:53 AM

Thursday, January 25, 2018 10:56:53 AM

Post# of 144823
Buyout Talk

I see a lot of people talking buyout with PMCB selling out completely and closing shop. Why would PMCB find a buyout based on their LAPC work to be more advantageous to the shareholders than some other arrangement (like selling/licensing only the specific CIAB rights for LAPC). There is still so much potential in their other areas of work like diabetes, cannabis therapies, Dr. Tong & China, etc to sell completely based on success in one area, isn't there? Seems as though PMCB could use the money from LAPC to invest heavily in R&D in these other areas and create even more benefit to shareholders. What do you all think?

BTW- I follow this board regularly and appreciate all of your posts and insight.

Go PMCB! Let's get to .08!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News